Skip to main content
Clinical Trials/NCT06166303
NCT06166303Not yet recruitingNot Applicable

Effect of Number of Previous Cesarean Sections on the Results of Angiogenic Factors. A Descriptive, Prospective Study.

Saint Thomas Hospital, Panama1 site in 1 country540 target enrollmentStarted: October 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
540
Locations
1
Primary Endpoint
Index sFlt-1/PIGF

Study Overview

Brief Summary

Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit.

Although the usefulness of angiogenic factors in these scenarios is known, little is known about the effects that other conditions might have on their serum levels, mainly those that have an effect on trophoblastic invasion, the process that initiates implantation of the pregnancy in the endometrium. The purpose of the present study is to assess the effect that a history of uterine surgery, such as caesarean section, might have on angiogenic factor scores in subjects with no history of a hypertensive disorder of pregnancy.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 36 weeks of gestation or more
  • Singleton pregnancy
  • Previous cesarean section (case)

Exclusion Criteria

  • Vasculitis
  • Twin pregnancy
  • Chronic endometritis
  • Renal failure
  • Liver disease
  • Thrombocytopenia

Outcomes

Primary Outcomes

Index sFlt-1/PIGF

Time Frame: From the moment of randomization up until delivery. Between 24-48 hours.

Angiogenic factors, normal value.

Secondary Outcomes

  • Progression to preeclampsia(Up until discharge. On average, 7 days)

Investigators

Sponsor
Saint Thomas Hospital, Panama
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Osvaldo A. Reyes T.

Head of the research deparment

Saint Thomas Hospital, Panama

Study Sites (1)

Loading locations...

Similar Trials